18F-FDG PET/CT in primary non-Hodgkin's lymphoma of the sinonasal tract

Ann Hematol. 2010 Jun;89(6):635-7. doi: 10.1007/s00277-009-0842-3. Epub 2009 Oct 21.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cyclophosphamide / administration & dosage
  • Cytarabine / therapeutic use
  • Dexamethasone / therapeutic use
  • Doxorubicin / administration & dosage
  • Fluorodeoxyglucose F18*
  • Humans
  • Lymphoma, Non-Hodgkin / diagnostic imaging*
  • Lymphoma, Non-Hodgkin / drug therapy
  • Middle Aged
  • Organoplatinum Compounds / therapeutic use
  • Paranasal Sinus Neoplasms / diagnostic imaging*
  • Paranasal Sinus Neoplasms / drug therapy
  • Paranasal Sinuses / diagnostic imaging
  • Paranasal Sinuses / pathology
  • Positron-Emission Tomography* / methods
  • Prednisone / administration & dosage
  • Prognosis
  • Remission Induction
  • Tomography, Emission-Computed* / methods
  • Vincristine / administration & dosage

Substances

  • Organoplatinum Compounds
  • Cytarabine
  • Fluorodeoxyglucose F18
  • Vincristine
  • Dexamethasone
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • CAV protocol
  • DHAOx protocol